NewLeaf Symbiotics
OverviewSuggest Edit
NewLeaf Symbiotics was formed to develop and commercialize one of the most prevalent, beneficial bacteria found in nature: PPFMs (Pink Pigmented Facultative Methylotrophs). NewLeaf Symbiotics is the exclusive licensee of a number of patents on the use of this family of bacteria. NewLeaf Symbiotics has also filed its own related patents, and is actively developing new technologies related to PPFMs. The Company is engaged in laboratory, greenhouse, and field product trials.
| Type | Private | |
| Founded | 1999 | |
| HQ | Creve Coeur, MO, US | Map |
| Website | newleafsym.com |
Latest Updates
| Employees (est.) (Feb 2021) | 40 | |
| Cybersecurity rating | B | More |
Key People/Management at NewLeaf Symbiotics
Steve Kahn
Chief Executive Officer, Director
Janne Kerovuo
Chief Technology Officer
Sanjeev Krishnan
Director
Mike McFatrich
Vice President Business Strategy & Development
John Pasquesi
Director
Maureen Mazurek
Vice President of Communications
NewLeaf Symbiotics Office Locations
NewLeaf Symbiotics has an office in Creve Coeur
Creve Coeur, MO, US (HQ)
1005 N Warson Rd
NewLeaf Symbiotics Financials and Metrics
Summary Metrics
Founding Date | 1999 |
NewLeaf Symbiotics total Funding | $57.6 m |
NewLeaf Symbiotics latest funding size | $6 m |
Time since last funding | 3 years ago |
NewLeaf Symbiotics investors | Open Prairie, Palo Alto Investors, Pangaea Ventures, Otter Capital, RockPort Capital, Lewis & Clark Ventures, Monsanto Growth Ventures (MGV), The Yard Ventures |
NewLeaf Symbiotics's latest funding round in September 2017 was reported to be $6 m. In total, NewLeaf Symbiotics has raised $57.6 m
NewLeaf Symbiotics Cybersecurity Score
NewLeaf Symbiotics Online and Social Media Presence
NewLeaf Symbiotics's Trends
NewLeaf Symbiotics News and Updates
July 10, 2017
NewLeaf Symbiotics nabs $24 mln Series C
St. Louis, Missouri-based NewLeaf Symbiotics, an agricultural biotech company, has secured $24 million in Series C financing. Monsanto Growth Ventures and Otter Capital led the round with participation from other backers that included Lewis & Clark Ventures, Rockport Capital, Pangaea Ventures an…
NewLeaf Symbiotics Blogs
December 01, 2020
NewLeaf Symbiotics Completes Final Close of Series D Financing with the Addition of a New Strategic Investor
NewLeaf Symbiotics completes final close of its Series D financing; SABIC Ventures US Holdings LLC joins as strategic investor ST. LOUIS, December 1, 2020 – NewLeaf Symbiotics, Inc. (NewLeaf) announced that it recently completed the final close of its Series D financing as it broadens and accelera…
August 27, 2020
Terrasym for Corn: Early Season Results
After extensively examining the data from our field trials, we’re excited to share insights from our early season field visits of Terrasym for Corn! Overview NewLeaf Symbiotics is partnering with independent data company IN10T and their expansive FarmerTrials Network this growing season to bring com…
May 29, 2020
NewLeaf Symbiotics to Host Virtual Field Day on June 1
ST. LOUIS, Mo – NewLeaf Symbiotics® is excited to host its first Virtual Field Day to showcase early season results of Terrasym®. The Virtual Field Day will give farmers and others in the agriculture community the opportunity to view Terrasym’s corn and soybean trial progress while minimizing in-per…
March 19, 2020
NewLeaf Symbiotics Partners with IN10T’s FarmerTrials Network to Demonstrate Benefits of Microbial Ag Products
For Release February 27, 2020 ST. LOUIS, Mo – NewLeaf Symbiotics (NewLeaf), a plant microbiome technology company, has initiated a partnership with IN10T® (“intent”) to test its M-troph microbial product line Terrasym® with farmers. The company will tap into IN10T’s extensive FarmerTrials Network to…
February 24, 2020
NewLeaf Symbiotics Raises $20 million in a first close of its Series D Financing, Focuses on Accelerating Commercialization
Farmers Poised to Benefit from NewLeaf’s Innovative Microbial Products ST. LOUIS, February 24, 2020 – NewLeaf Symbiotics, Inc. (NewLeaf) announced today that it has raised $20 million in a first close of its Series D financing as it broadens and accelerates product commercialization. Koch Agronomic …
October 03, 2019
Microbes Play a Crucial Role in Farming, a Thirty Year Journey
by Desmond Jimenez, Chief Product Officer July was significant for NewLeaf Symbiotics and agriculture. We announced a long-term partnership with Joyn Bio. Together, New Leaf and Joyn will work collectively to accelerate our shared vision to bring economic innovation and ecological resilience to glob…
NewLeaf Symbiotics Frequently Asked Questions
When was NewLeaf Symbiotics founded?
NewLeaf Symbiotics was founded in 1999.
Who are NewLeaf Symbiotics key executives?
NewLeaf Symbiotics's key executives are Steve Kahn, Janne Kerovuo and Sanjeev Krishnan.
How many employees does NewLeaf Symbiotics have?
NewLeaf Symbiotics has 40 employees.
Who are NewLeaf Symbiotics competitors?
Competitors of NewLeaf Symbiotics include Joyn Bio, Anpario and Biotalys.
Where is NewLeaf Symbiotics headquarters?
NewLeaf Symbiotics headquarters is located at 1005 N Warson Rd, Creve Coeur.
Where are NewLeaf Symbiotics offices?
NewLeaf Symbiotics has an office in Creve Coeur.
How many offices does NewLeaf Symbiotics have?
NewLeaf Symbiotics has 1 office.
Learn about Craft real-time company insights
Receive alerts for 300+ data fields across thousands of companies